Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 250
Single User License Price INR 17500
Corporate User License Price USD 750
Corporate User License Price INR 52500
Site License Price USD 500
Site License Price INR 35000
Request a Quote

Report Title

Nichi-Iko Pharmaceutical Co Ltd (4541) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Quote Request for License Type
License Type Price  
Single User License USD 250
Site License USD 500
Enterprise Wide License USD 750
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Nichi-Iko Pharmaceutical Co Ltd (4541) - Pharmaceuticals & Healthcare - Deals and Alliances Profile


Quote Request for License Type
License Type Price  
Single User License USD 250
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Nichi-Iko Pharmaceutical Co Ltd (4541) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Nichi-Iko Pharmaceutical Co Ltd (4541) - Pharmaceuticals & Healthcare - Deals and Alliances Profile



Executive Summary

Summary

Nichi-Iko Pharmaceutical Co Ltd (Nichi-Iko) is a manufacturer of generic products. The company eripheral nervous system medicines. The company offers products such as alacepril tablets, aluminum hydroxide gel, aranidipine capsules, bacampicillin hydrochloride tablets, barium sulfate, betahistine mesilate tablets, calcium gluconate hydrate powder, candesartan cilexetil tablets and diltiazem hydrochloride table, among others. Its products are used for treatments of circulatory, digestive, respiratory, central and peripheral nervous systems. Nichi-Iko offers manufacturing, sales, distribution, export, import and related activities for various types of pharmaceuticals. The company operates in Sapporo, Sendai, Kanto, Tokai-Hokuriku, Osaka, Hiroshima, Fukuoka, and others. Nichi-Iko is headquartered in Toyama, Japan.

Nichi-Iko Pharmaceutical Co Ltd (4541)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Nichi-Iko Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Nichi-Iko Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Nichi-Iko Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Nichi-Iko Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Nichi-Iko Pharmaceutical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 10

Nichi-Iko Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Nichi-Iko Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deal Details 12

Asset Purchase 12

Sagent Pharma Acquires Product Portfolio from Teva Pharma and Actavis for USD40 Million 12

Nichi-Iko Pharma Acquires Pharmaceutical Manufacturing Business from Astellas Pharma Tech 13

Partnerships 14

Lupin and Nichi-Iko Enter into Partnership Agreement 14

Eisai Enters into Agreement with Nichi-Iko Pharma 15

Nichi-Iko Pharma Enters Into Co-Marketing Agreement With Biolab 16

Equity Offering 17

Sagent Pharma Completes Public Offering Of Shares For USD 75.3 Million 17

Acquisition 19

Nichi-iko Pharma Acquires Sagent Pharma for USD734.2 Million in Tender Offer 19

Sanofi to Sell 4.76% Stake in Nichi-iko Pharma 21

Hong Kong King-Friend Pharmaceutical Acquires 100% Stake in Sagent (China) Pharma From Sagent Pharma 22

Nichi-Iko Pharma Divests 12.6% Stake in Binex for USD50 Million 23

Sagent Pharma Acquires Omega Labs for USD85.3 Million 24

Zhejiang Hisun Pharma Plans to Divest Stake in Sagent Pharma 26

Sagent Pharma Acquires Remaining 50% JV Stake in Kanghong Sagent from Chengdu Kanghong Pharma for USD25 Million 27

Nichi-Iko Pharma Acquires 69% Stake In Yakuhan Pharma 28

Nichi-Iko Pharmaceutical Co Ltd-Key Competitors 29

Nichi-Iko Pharmaceutical Co Ltd-Key Employees 30

Nichi-Iko Pharmaceutical Co Ltd-Locations And Subsidiaries 31

Head Office 31

Other Locations & Subsidiaries 31

Joint Venture 32

Recent Developments 33

Strategy And Business Planning 33

Apr 17, 2018: Nichi-Iko Pharmaceutical: Announcement of completion of new production facility by Aprogen Biologics 33

Financial Announcements 34

Feb 07, 2018: Nichi-Iko Pharmaceutical Reports Consolidated Financial Results for the 3rd Quarter of the Fiscal Year Ending March 31, 2018 34

Appendix 36

Methodology 36

About GlobalData 36

Contact Us 36

Disclaimer 36

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

Nichi-Iko Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Nichi-Iko Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Nichi-Iko Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Nichi-Iko Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Nichi-Iko Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Nichi-Iko Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Nichi-Iko Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Nichi-Iko Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Nichi-Iko Pharmaceutical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 10

List of Tables

Nichi-Iko Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2

Nichi-Iko Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Nichi-Iko Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Nichi-Iko Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Nichi-Iko Pharmaceutical Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8

Nichi-Iko Pharmaceutical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 10

Nichi-Iko Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Sagent Pharma Acquires Product Portfolio from Teva Pharma and Actavis for USD40 Million 12

Nichi-Iko Pharma Acquires Pharmaceutical Manufacturing Business from Astellas Pharma Tech 13

Lupin and Nichi-Iko Enter into Partnership Agreement 14

Eisai Enters into Agreement with Nichi-Iko Pharma 15

Nichi-Iko Pharma Enters Into Co-Marketing Agreement With Biolab 16

Sagent Pharma Completes Public Offering Of Shares For USD 75.3 Million 17

Nichi-iko Pharma Acquires Sagent Pharma for USD734.2 Million in Tender Offer 19

Sanofi to Sell 4.76% Stake in Nichi-iko Pharma 21

Hong Kong King-Friend Pharmaceutical Acquires 100% Stake in Sagent (China) Pharma From Sagent Pharma 22

Nichi-Iko Pharma Divests 12.6% Stake in Binex for USD50 Million 23

Sagent Pharma Acquires Omega Labs for USD85.3 Million 24

Zhejiang Hisun Pharma Plans to Divest Stake in Sagent Pharma 26

Sagent Pharma Acquires Remaining 50% JV Stake in Kanghong Sagent from Chengdu Kanghong Pharma for USD25 Million 27

Nichi-Iko Pharma Acquires 69% Stake In Yakuhan Pharma 28

Nichi-Iko Pharmaceutical Co Ltd, Key Competitors 29

Nichi-Iko Pharmaceutical Co Ltd, Key Employees 30

Nichi-Iko Pharmaceutical Co Ltd, Other Locations 31

Nichi-Iko Pharmaceutical Co Ltd, Subsidiaries 32

Nichi-Iko Pharmaceutical Co Ltd, Joint Venture 32

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Nichi-Iko Pharmaceutical Co Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand

person